Parkinson's disease (PD) is a prevalent neurodegenerative disorder that occurs in old age due to a decrease in dopamine, which causes nerve cell destruction. This disease is difficult to diagnose since its symptoms are similar to those of the aging process. Those with PD have impaired motor control and function, dyskinesia, and tremors. To treat PD, drugs that enhance the amount of dopamine given to the brain are administered to alleviate symptoms. This inquiry examines the prescription of rotigotine to achieve this objective. The primary objective of this review is to examine the usage of rotigotine in both the late and early stages of PD. The statistical model utilized in the review found that there was not a significant difference in the dosage of rotigotine prescribed to late and early-stage PD patients, however, there were some confounding variables that may have skewed this result; therefore, further research is necessary to validate or nullify this hypothesis.
Although it is not a very common condition, people who have suffered from neuro-damage or neurodiseases are at risk for developing a condition known as Alien hand syndrome (AHS). Individuals who have this condition are unable to control the movement of their hands for certain brief intervals of time. In order to improve upon the treatment of individuals with AHS, it is important that signs and symptoms of the disease are identified as soon as possible. The purpose of this investigation is to catalog the data regarding the pre-existing conditions and the method of diagnosis for AHS. Within the review, it was revealed that stroke was the most common pre-existing condition for the disease. Therefore, physicians who have stroke patients within their care should carefully monitor their condition in case they do develop AHS. Additionally, it was found that using an MRI machine was the most common method of diagnosing a patient with AHS. This was most likely because MRI scans provide the most information about a patient's brain functionality which can be used to deduce if an individual has AHS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.